Colitis clinical trials
The registry lists 1,074 studies for Colitis across more than 10 countries. 134 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.
Status
- Completed
- 585
- Status unknown
- 151
- Terminated
- 131
- Recruiting
- 87
- Withdrawn
- 50
- Not yet recruiting
- 42
Phase
- Phase 2
- 255
- Phase 3
- 175
- Phase 1
- 128
- Phase 4
- 75
- Early Phase 1
- 13
Where
- United States
- 363
- Canada
- 156
- Germany
- 146
- France
- 126
- Poland
- 122
- Italy
- 114
Who runs them
Pfizer (20) · Ferring Pharmaceuticals (18) · Takeda (18) · AbbVie (18) · Shire (16) · Assiut University (14) · Bristol-Myers Squibb (12) · Bausch Health Americas, Inc. (12)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,074 — search for more.
- Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)RecruitingNCT07513181Phase 21 country
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 11 country
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 218 countries
- Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)RecruitingNCT07582458Phase 2/31 country
- Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisNot yet recruitingNCT07646223Phase 21 country
- Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With CancerRecruitingNCT06337695Phase 2/31 country
- Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative ColitisEnrolling by invitationNCT07786389Phase 1/21 country
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruitingNCT07012395Phase 235 countries
- A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative ColitisRecruitingNCT07470879Phase 210 countries
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRecruitingNCT06598943Phase 221 countries
- Autologous Stem Cell Transplant for Crohn's DiseaseRecruitingNCT03219359Phase 21 country
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 11 country
- Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease ManagementEnrolling by invitationNCT06424769Not applicable1 country
- A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi ArabiaRecruitingNCT075412611 country
- R-3750 in Patients With Mild to Moderate Ulcerative ColitisRecruitingNCT05666960Phase 11 country
- A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related ColitisRecruitingNCT05726396Phase 21 country
- AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative ColitisRecruitingNCT07619638Not applicable1 country
- PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureNot yet recruitingNCT07619898Phase 2
- Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesRecruitingNCT07427017Phase 21 country
- KAN-004 for Immune-Related Diarrhea or ColitisRecruitingNCT07196410Phase 11 country
- FMT in Checkpoint Inhibitor-mediated Diarrhea and ColitisRecruitingNCT06206707Not applicable1 country
- Early Vedolizumab as First-Line for Immune-Related Colitis Therapy TrialRecruitingNCT06841705Phase 21 country
- Body Composition Assessment and Monitoring in Inflammatory Bowel DiseaseRecruitingNCT071627011 country
- Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for ColitisRecruitingNCT07047339Phase 2/31 country
- Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative ColitisRecruitingNCT06660693Phase 31 country
- Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective StudyNot yet recruitingNCT06998797
- Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative ColitisRecruitingNCT04743518Phase 41 country
- Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel DiseaseNot yet recruitingNCT06878495Not applicable
- Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative ColitisRecruitingNCT06231264Not applicable1 country
- Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing InterventionRecruitingNCT067507311 country
- The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis DiseaseNot yet recruitingNCT06959654Not applicable
- A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted TherapiesRecruitingNCT054568931 country
- Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel DiseaseRecruitingNCT05733845Not applicable1 country
- QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative ColitisRecruitingNCT04030676Not applicable1 country
- hucMSCs Exosomes for the Treatment of Active Ulcerative ColitisNot yet recruitingNCT06853522Early Phase 11 country
- A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative ColitisNot yet recruitingNCT06918093
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative ColitisRecruitingNCT06895252Not applicable1 country
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced TherapiesRecruitingNCT06906445Not applicable1 country
- Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitisRecruitingNCT068997891 country
- LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)Not yet recruitingNCT06749795Phase 11 country
- Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal InflammationRecruitingNCT065163411 country
- Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with ColitisNot yet recruitingNCT06874673Not applicable1 country
- Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative ColitisRecruitingNCT06595719Not applicable1 country
- Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the TreatmentNot yet recruitingNCT06867042Phase 2
- Beneficial Effect of Silymarin in Ulcerative ColitisRecruitingNCT06213857Phase 21 country
- Metformin as Added on Therapy in Patients With Ulcerative ColitisRecruitingNCT05574387Phase 21 country
- Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager ProjectRecruitingNCT054796171 country
- Whey Protein Milk-Derived ExosomesNot yet recruitingNCT06755021Not applicable
- Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)Not yet recruitingNCT068330211 country
- Alpha Lipoic Acid in Ulcerative ColitisRecruitingNCT06067698Not applicable1 country